GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Profit Margin History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Profit Margin (%) | 26.11 | 24.12 | 17.43 | 18.87 | 12.49 |
What is the latest Cash Profit Margin ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash Profit Margin |
|---|---|
| Mar2026 | 26.11 |
| Mar2025 | 24.12 |
| Mar2024 | 17.43 |
| Mar2023 | 18.87 |
| Mar2022 | 12.49 |
How is Cash Profit Margin of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash Profit Margin | % Change | |
|---|---|---|---|
| Mar2026 | 26.11 | 8.25 | |
| Mar2025 | 24.12 | 38.38 | |
| Mar2024 | 17.43 | -7.63 | |
| Mar2023 | 18.87 | 51.08 | |
| Mar2022 | 12.49 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Profit Margin ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹40,823.7 Cr | -0.3% | 10.4% | -28.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -0.3% |
10.4% |
-28.3% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses